Publications 2004

[ Latest publications ] [ 2007 ] [ 2006 ] [ 2005 ] [ 2004 ]

List of publications from the Consortium 2004.

[ View abstracts of all the articles>> ]

Coluccia AM, Perego S, Cleris L, Gunby RH, Passoni L, Marchesi E, Formelli F, Gambacorti-Passerini C.

Bcl-XL downregulation suppresses the tumorigenic potential of NPM/ALK in vitro and in vivo

Blood, 2004, 103, 2787-2794.

[ Full article ] (Pdf,  277 KB)

 Abstract >>

 

Gambacorti-Passerini C, Piazza R, Tornaghi L, Pilotti S, Pogliani E.

Development of c-Kit-expressing Small-Cell Lung Cancer in a Chronic Myeloid Leukemia Patient during Imatinib Treatment

J. Natl. Cancer Inst. 2004, 96, 1723-24.

Full article >>
[ Full article ] (Pdf,  187 KB)
[ Erratum ] (Pdf,  15 KB)
 

Gambacorti-Passerini C.

Imatinib mesylate associated with delayed hematopoietic recovery after concomitant chemotherapy - response.

Leukemia, 2004, 18, 887-888.

Full article >>

 
 Meggio, F., Pagano, M.A., Moro, S., Zagotto, G., Ruzzene, M., Sarno, S., Cozza, G., Bain, J., Elliott, M., Donella Deana, A., Brunati, A.M.,
and Pinna, L.A. (2004):

Inhibition of protein kinase CK2 by condensed polyphenolic derivatives. An in vitro and in vivo study

Biochemistry, 2004, 43, 12931-12936.

 Abstract >>
[ Full article ] (Pdf,  112 KB)

 

Pagano, M.A., Meggio, F., Ruzzene, M., Andrzejewska, M., Kazimierczuk, Z. and
Pinna, L.A. (2004):

2-dimethylamino-4,5,6,7-tetrabromo-1H-benzimidazole: a novel powerful and selective inhibitor of protein kinase CK2

Biochem. Biophys. Res. Commun. 2004, 321, 1040-1044.

Full article >>
[ Full article ] (Pdf,  306 KB)
 

Pagano M. A., Andrzejeska M., Ruzzene M., Sarno S., Cesaro L., Bain J., Elliott M., Meggio F., Kazimierczuk Z., and Pinna L. A. (2004):

Optimization of protein kinase CK2 inhibitors derived from 4,5,6,7-tetrabromobenzimidazole

J. Med. Chem. 47, 6239-6247.

Full article >>